Daniel Poole
Has grant
Associate Professor and Laboratory Head
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Daniel Poole is an Associate Professor and Laboratory Head at Monash University in Australia. His research focuses on the neural control of gastrointestinal function, including the interactions of immune cells within the enteric nervous system. Recent publications highlight his work on innovative approaches to understand chronic pain and develop therapeutic strategies for gastrointestinal motility disorders.
Recent Grants
Grant: Open
Treating tiny tummies: Next generation cell therapies for paediatric gut disorders
Open Date: 2024-06-06
Close Date: 2029-05-31
Grant: Close
Harnessing Endogenous Opioids to Treat Gut Motility Disorders and Pain
Open Date: 2022-12-14
Close Date:
Grant: Close
The SPRINTS Project: Stroke - Prevention of Reperfusion Injury and Neuroinflammation - a Therapeutic Strategy
Open Date: 2021-06-11
Close Date: 2025-05-31
Grant: Close
Caveospheres: A versatile peptide delivery system
Open Date: 2020-01-01
Close Date: 2022-12-31
Grant: Close
Spatial and temporal dimensions of mu-opioid receptor signalling: implications for the development of tolerance
Open Date: 2017-01-01
Close Date: 2019-01-01
Articles (10)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Background Gut dysmotility is common after ischemic stroke, but the mechanism underlying this response is unknown. Under homeostasis, gut motility is regulated by the neurons of the enteric nervous system that control contractile/relaxation activity of muscle cells in the gut wall. More recently, studies of gut inflammation revealed interactions of macrophages with enteric neurons are also involved in modulating gut motility. However, whether poststroke gut dysmotility is mediated by direct signaling to the enteric nervous system or indirectly via inflammatory macrophages is unknown. Methods and Results We examined these hypotheses by using a clinically relevant permanent intraluminal midcerebral artery occlusion experimental model of stroke. At 24 hours after stroke, we performed in vivo and ex vivo gut motility assays, flow cytometry, immunofluorescence, and transcriptomic analysis. Stroke‐induced gut dysmotility was associated with recruitment of muscularis macrophages into the gastrointestinal tract and redistribution of muscularis macrophages away from myenteric ganglia. The permanent intraluminal midcerebral artery occlusion model caused changes in gene expression in muscularis macrophages consistent with an altered phenotype. While the size of myenteric ganglia after stroke was not altered, myenteric neurons from post–permanent intraluminal midcerebral artery occlusion mice showed a reduction in neuronal nitric oxide synthase expression, and this response was associated with enhanced intestinal smooth muscle contraction ex vivo. Finally, chemical sympathectomy with 6‐hydroxydopamine prevented the loss of myenteric neuronal nitric oxide synthase expression and stroke‐induced slowed gut transit. Conclusions Our findings demonstrate that activation of the sympathetic nervous system after stroke is associated with reduced neuronal nitric oxide synthase expression in myenteric neurons, resulting in impaired smooth muscle relaxation and dysregulation of gut transit.
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Collaborators (9)
Ayame Saito
Teaching Associate
MONASH UNIVERSITY
Estibaliz Gómez-de-Mariscal
Instituto Gulbenkian de Ciência
Connie H. Y. Wong
-
Nicola Laraine Harris
MONASH UNIVERSITY
Nicholas Veldhuis
MONASH UNIVERSITY
Arthur Christopoulos
MONASH UNIVERSITY
Celine Valant
MONASH UNIVERSITY
Chloe Peach
Assistant Professor in Molecular Pharmacology
University of Nottingham
Wendy Imlach
MONASH UNIVERSITY
Make your next move.
Prepare your application
Review drafts before you send them.